Effect of Coadministered Ketoconazole, a Strong Cytochrome P450 3A4 Enzyme Inhibitor, on the Pharmacokinetics of Ciclesonide and its Active Metabolite Desisobutyryl-Ciclesonide

Author： Böhmer Gabriele M.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.5, 2008-01, pp. : 343-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling: Two Cytochrome P450 3A4 Substrates Coadministered with Ketoconazole or Verapamil

By Perdaems Nathalie  

Clinical Pharmacokinetics, Vol. 49, Iss. 4, 2010-04 ,pp. : 239-258

Adis International

Access to resources Recommend Favorite

Equivalent Pharmacokinetics of the Active Metabolite of Ciclesonide With and Without Use of the AeroChamber Plus™ Spacer for Inhalation

By Drollmann Anton  

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 729-736

Adis International

Access to resources Recommend Favorite

Ciclesonide

By Reynolds N.A.   Scott L.J.  

Drugs, Vol. 64, Iss. 5, 2004-01 ,pp. : 511-519

Adis International

Access to resources Recommend Favorite

The Metabolism of Zolmitriptan: Effects of an Inducer and an Inhibitor of Cytochrome P450 on its Pharmacokinetics in Healthy Volunteers

By Dixon R.   French S.   Kemp J.   Sellers M.   Yates R.  

Clinical Drug Investigation, Vol. 15, Iss. 6, 1998-06 ,pp. : 515-522

Adis International

Access to resources Recommend Favorite

Effects of Enzyme Sources on Midazolam 1-Hydroxylation Activity Catalyzed by Recombinant Cytochrome P450 3A4 in Combination with NADPH-Cytochrome P450 Reductase

By  

Drug Metabolism Letters, Vol. 2, Iss. 3, 2008-08 ,pp. : 190-192

Bentham Science Publishers

Access to resources Recommend Favorite